A Grade Is Confidence, Not a Promise

What a grade actually claims

An EBL grade measures one thing: how confident we are in the average result from human trials. A high grade means the effect showed up reliably, across studies and across people. It does not promise the same effect in you. Averages hide spread, and that is true of every intervention on the site, including the A-graded ones.

So the premise is correct. Individual variation is real, and a population average is not a personal guarantee. Where the popular advice usually goes wrong is in what it offers as the fix.

Two ways to get this wrong

Why predicting it from your genes mostly does not work yet

The largest randomized trial of personalized nutrition ran exactly this test. It compared generic advice against advice personalized on diet, on diet plus phenotype (your measurements and blood markers), and on diet plus phenotype plus genotype. Personalized advice did beat generic advice. But adding the phenotype and genotype layers did not improve on personalization that used diet alone. The genetic readout added no extra predictive power over simply knowing what a person already ate.

There is a real exception, and it is worth being precise about it. For a small number of specific prescription drugs, pharmacogenetic testing is validated and used in the clinic, because a single gene can change how the body metabolizes that exact drug. That is a narrow, well-defined case. It does not extend to predicting which supplement or nootropic will work for your brain. Borrowing the credibility of drug pharmacogenomics to sell a consumer gene panel for supplements is the move to watch for.

The part almost nobody mentions

A great deal of what looks like individual response is not biology. It is noise.

Researchers who study this directly have shown that the normal within-person variation in any measurement, the kind you get even with gold-standard tools, is often large enough to explain all of the apparent difference between so-called responders and non-responders. The only way to confirm a true individual response is to test the same person against a control condition more than once, a replicate crossover A trial design in which each participant receives both the treatment and the comparison, one after the other, and serves as their own control. or n-of-1 design. Most "this worked uniquely for me" stories have never met that bar. They are regression to the mean wearing a lab coat.

So when someone reports testing hundreds of compounds over many years and learning which ones their unique biology responds to, the honest reading is that uncontrolled self-experimentation cannot actually separate a real personal response from chance. The narrative is compelling. The method cannot deliver what it claims.

What EBL does instead: test, intervene, retest

You do not need to predict your response in advance. You measure it. That is the loop the whole platform is built around.

1. The evidence narrows the field. The grade shows where the human trials are strongest, so the conversation with your clinician can start from a short list rather than two hundred options.
2. A baseline gets measured. The biomarker A measurable sign in the body, such as a blood test value, used to track a condition or the effect of a treatment. or function an intervention is supposed to change is measured before anything starts.
3. Retesting shows what moved. The follow-up measurement shows whether the number changed in a direction that matters. Interpreting that result, and deciding what follows from it, is your clinician's call.

The discipline that makes this honest rather than wishful: give it enough time, change one thing at a time where you can, and where it matters, repeat the measurement so a single noisy reading does not fool you. That is the n-of-1 logic, applied practically rather than promised in a brochure.

The honest middle

EBL sits between the two errors. Not one protocol for everyone. Not a promise that your biology can be read in advance and the experiment skipped. The evidence tells you what may work. Your own measurements show what changed in you, though a single before-and-after reading cannot by itself show what caused the change. Anyone selling a validated shortcut around that second step is selling something that does not exist yet.

Primary sources: Food4Me RCT (Int J Epidemiol) · True and false interindividual differences (Exp Physiol)